ResearchMoz

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

Transparency Market Research
Published Date » 2012-10-08
No. Of Pages » 130
   
 This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives.  
   
  This report highlights...
TABLE OF CONTENTS

CHAPTER 1 PREFACE
1.1 KEY POINTS COVERED
1.2 REPORT DESCRIPTION
1.3 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY AND MARKET OVERVIEW

CHAPTER 3 INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS
3.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017
3.1.1 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET, 2010 V/S 2017
3.1.2 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017
GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017
3.2 POPULATION GROWTH TREND
3.2.1 GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP
3.2.2 INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY GEOGRAPHY
3.3 CAUSES OF INFERTILITY
3.4 MARKET DYNAMICS
3.4.1 DRIVERS
3.4.1.1 Rising number of infertile people
3.4.1.2 Increasing worldwide obesity
3.4.1.3 Rising disposable incomes of the consumers
3.4.1.4 Lifestyle hazards such as rising number of smokers, stress and pollution
3.4.1.5 Adoption of babies by homosexual couples
3.4.1.6 Availability of government support for infertility abatement procedures
3.4.2 INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS
3.4.3 RESTRAINTS
3.4.3.1 Limited insurance covers
3.4.3.2 Religious bans on artificial insemination procedures especially the Islamic bans
3.4.3.3 Risk of repeat procedures
3.4.3.4 Traditional infertility treatments such as the Chinese infertility treatments
3.4.3.5 Ban on artificial reproduction procedures in European countries especially Turkey, Germany, Italy and France
3.4.3.6 Patent expiration of infertility drugs
3.4.4 INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
3.4.5 OPPORTUNITY
3.4.5.1 Technological advancements in the Asia Pacific region and the developmental activities in the region
3.4.5.2 Medical tourism initiatives in the developing countries
3.4.5.3 Need for more ART cycles
3.1 MARKET SHARE ANALYSIS, 2011
3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET
3.2.1 BARGAINING POWER OF SUPPLIERS
3.2.1 BARGAINING POWER OF BUYERS
3.2.2 THREAT OF NEW ENTRANTS
3.2.3 THREAT OF SUBSTITUTES
3.2.4 COMPETITIVE RIVALRY

CHAPTER 4 INFERTILITY DRUGS AND DEVICES MARKET SEGMENTATION
4.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES
4.1.1 FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.1.1 Global Infertility drugs and devices market by Endometriosis female infertility types
4.1.1.2 Global Infertility drugs and devices market by Ovarian disorder female infertility types
4.1.1.3 Global Infertility drugs and devices market by Uterine disorder female infertility types
4.1.1.4 Global Infertility drugs and devices market by Tubal disorder female infertility types
4.1.1.5 Global Infertility drugs and devices market by Hormonal disorder female infertility types
4.1.2 MALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.2.1 Global Infertility drugs and devices market by Azoospermia male infertility types
4.1.2.2 Global Infertility drugs and devices market by Varicocele male infertility types
4.1.2.3 Global Infertility drugs and devices market by Ejaculation Disorder male infertility types
4.1.2.4 Global Infertility drugs and devices market by Erectile Dysfunction male infertility types
4.2 INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY
4.2.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION
4.2.2 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED REPRODUCTIVE TECHNOLOGIES (USD THOUSAND) 
4.2.3 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO FERTILIZATION (USD THOUSAND) 
4.2.4 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD THOUSAND) 57

CHAPTER 5 REGION-WISE ANALYSIS
5.1 INFERTILITY DRUGS AND DEVICES MARKET BY REGION
5.1.1 EUROPE INFERTILITY DRUGS AND DEVICES MARKET
5.1.1.1 U.K
5.1.1.2 France
5.1.1.3 Germany
5.1.1.4 Italy
5.1.1.5 Spain
5.1.2 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3.1 U.S
5.1.3.2 CANADA
5.1.3.3 MEXICO
5.1.4 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5.1 Japan
5.1.5.2 India
5.1.5.3 China
5.1.6 ROW INFERTILITY DRUGS AND DEVICES MARKET
5.1.7 ROW INFERTILITY DRUGS AND DEVICES MARKET
  5.1.7.1 Brazil’s Infertility drugs and devices market

CHAPTER 6 COMPANY PROFILES
6.1 JOHNSON & JOHNSON
6.1.1 COMPANY OVERVIEW
6.1.2 FINANCIAL OVERVIEW
6.1.3 BUSINESS STRATEGIES
6.1.4 RECENT DEVELOPMENTS
6.2 MERCK
6.2.1 COMPANY OVERVIEW
6.2.2 FINANCIAL OVERVIEW
6.2.3 BUSINESS STRATEGIES
6.2.4 PRODUCT PORTFOLIO
6.2.5 RECENT DEVELOPMENT
6.3 TEVA PHARMACEUTICALS
6.3.1 COMPANY OVERVIEW
6.3.2 FINANCIAL OVERVIEW
6.3.3 BUSINESS STRATEGIES
6.3.4 PRODUCT PORTFOLIO
6.3.5 RECENT DEVELOPMENTS
6.4 ORIGIO
6.4.1 COMPANY OVERVIEW
6.4.2 FINANCIAL OVERVIEW
6.4.3 BUSINESS STRATEGIES
6.4.4 PRODUCT PORTFOLIO
6.4.5 RECENT DEVELOPMENTS
6.5 BAYER
6.5.1 COMPANY OVERVIEW
6.5.2 FINANCIAL OVERVIEW
6.5.3 BUSINESS STRATEGIES
6.5.4 PRODUCT PORTFOLIO
6.5.5 RECENT DEVELOPMENT

List of Tables

LIST OF TABLES

TABLE 1 IMPACT ANALYSIS OF DRIVERS
TABLE 2 IMPACT ANALYSIS OF RESTRAINTS
TABLE 3 GLOBAL FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 4 GLOBAL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 5 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 6 U.K  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 7 U.K POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 8 U.K MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 9 U.K FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 10 U.K INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 11 U.K INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 12 FRANCE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 13 FRANCE POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 14 FRANCE MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 15 FRANCE FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 16 FRANCE INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 17 FRANCE INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 18 GERMANY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 19 GERMANY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 20 GERMANY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 21 GERMANY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 22 GERMANY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND 
TABLE 23 GERMANY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 24 ITALY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 25 ITALY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 26 ITALY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 27 ITALY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 28 ITALY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 29 ITALY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 30 SPAIN INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 31 SPAIN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 32 SPAIN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 33 SPAIN FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 34 SPAIN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 35 SPAIN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 36 U.S INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 37 U.S POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 38 U.S MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 39 U.S MALE INFERTILITY POPULATION TREATED, 2010 - 2017 (THOUSAND) 
TABLE 40 U.S FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 41 U.S INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 42 U.S INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 43 CANADA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 44 CANADA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 45 CANADA MALE INFERTILITY POPULATION PREVALENCE 2010 - 2017 (THOUSAND) 
TABLE 46 CANADA FEMALE INFERTILITY POPULATION PREVALENCE, 2010 – 2017 (THOUSAND) 
TABLE 47 CANADA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 48 CANADA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 49 MEXICO INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 50 MEXICO POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 51 MEXICO MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 52 MEXICO FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 53 MEXICO INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 54 MEXICO INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 55 JAPAN  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 56 JAPAN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 57 JAPAN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 58 JAPAN FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (MILLION) 
TABLE 59 JAPAN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 60 JAPAN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD MILLION) 
TABLE 61 INDIA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 62 INDIA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 63 INDIA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND
TABLE 64 INDIA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 65 INDIA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 66 INDIA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 67 CHINA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 68 CHINA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 69 CHINA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 70 CHINA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 71 CHINA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 72 CHINA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 73 ROW  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 74 ROW FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 75 ROW INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 76 BRAZIL  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 77 BRAZIL POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 78 BRAZIL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 79 BRAZIL FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 80 BRAZIL INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 81 BRAZIL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

List of Figures

LIST OF FIGURES

FIG. 1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 2 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET SHARE, 2010 VS 2017 
FIG. 3 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 4 GLOBAL POPULATION TREND, MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 5 GLOBAL FERTILE MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 6 GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 7 MARKET ATTRACTIVENESS - INFERTILITY DRUGS AND DEVICES MARKET BY GEOGRAPHY 
FIG. 8 CAUSES OF INFERTILITY 
FIG. 9 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET 
FIG. 10 COMPARITIVE ANALYSIS OF INFERTILITY DRUGS AND DEVICES MARKET SHARE BY GEOGRAPHY, 2010 AND 2017 (%) 
FIG. 11 EUROPE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 12 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 13 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 14 DECLINING FERTILITY RATE IN JAPAN, 2007 - 2011 
FIG. 15 ROW INFERTILITY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 16 JOHNSON & JOHNSON’S ANNUAL SALES, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 – 2010 (%) 
FIG. 17 MERCK’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 18 TEVA PHARMACEUTICAL’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 19 ORIGIO’S ANNUAL REVENUE, 2010 – 2011 (USD MILLION) 
FIG. 20 BAYER’S ANNUAL SALES, 2010 – 2011 (USD MILLION) 

Upcoming Reports:

Poland: vitamins market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the vitamins market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the vitamins market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Bio-Implants Market - Global Industry Analysis, Market Size, Market Share And Forecast, 2012 - 2018
By - Transparency Market Research
Bio-implants are bioengineered products known to be of human or animal origin used in the different fields of ENT. Generally, these bio-implants are offered for safeguarding after tissue replacement. These bio-implants are made up of biosynthetic materials known as collagen or it can also be made with tissue-engineered products such as artificial tissues or skin. Bio-implants cover a wide variety of products such as orthopedic artificial implants and cardiac pacemakers as these products are implanted completely in the body of the patient. North America is estimated to be the...
Animal Feed Organic Trace Minerals Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019
By - Transparency Market Research
Organic trace minerals are used in small quantity to improve the quality of food/ feed. Trace minerals have vital role in maintaining animal health. The rate of absorbing the food increases with the presence of trace minerals in the feed. Organic trace minerals have more preference over the inorganic minerals due to their health benefits and impacts on the taste of the feed.  The market is segmented on the basis of product types such as zinc, copper, cobalt, manganese, selenium and iron among others. The segmentation is done according to their requirements in animal feed, the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...